tobramycin has been researched along with dactinomycin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Herdewijn, P; Maiti, M; Nauwelaerts, K | 1 |
De Fabritiis, S; Di Bonaventura, G; Di Nicola, M; Lupetti, V; Piccirilli, A; Pompilio, A; Porreca, A | 1 |
Dan, K; Furuya, T; Harada, Y; Hirosawa, S; Ikeda, Y; Kawaguchi, M; Kawamata, N; Kawano, K; Kikuchi, M; Matsuoka, S; Murakami, H; Onozawa, Y; Oshimi, K; Sawanobori, M; Shirota, T; Suzuki, K; Takeuchi, J; Tomoyasu, S; Toyama, K; Tsuruoka, N; Uchida, Y; Wakasugi, K; Yaguchi, M; Yamada, T; Yamamoto, K | 1 |
1 trial(s) available for tobramycin and dactinomycin
Article | Year |
---|---|
[Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infections; Male; Middle Aged; Sepsis; Tobramycin | 1999 |
6 other study(ies) available for tobramycin and dactinomycin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional | 2012 |
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis
Topics: Anti-Bacterial Agents; Biofilms; Ciclopirox; Cystic Fibrosis; Dactinomycin; Drug Repositioning; Extracellular Polymeric Substance Matrix; Fluorouracil; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Ribavirin; Tobramycin | 2022 |